Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Comparing two techniques for biceps tendon repair in patients without rotator cuff tears

Official title: Biceps Tenodesis With 360 Suture Anchor Versus Self-Locking Tenodesis in the Absence of Full-thickness Rotator Cuff Tears: Protocol for a Non-inferiority Randomized Controlled Trial (BLAST-2)

Run by Clinique Générale dAnnecy · NCT06772103 · Data updated 2026-11-12

This study is testing two different surgical methods for fixing biceps tendon problems in patients who don’t have rotator cuff tears to see which one works better.

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment98 (estimated)
SponsorClinique Générale dAnnecy
Academic / other
Locations1 site (Annecy)
StatusRecruiting
StartedJanuary 22, 2025
Main results expectedJanuary 1, 2030
Study endsJanuary 1, 2030
Registry record updatedJuly 9, 2026
Trial IDNCT06772103 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with tendinopathy of the long head of the biceps or SLAP lesions without rotator cuff tears.

Probably not a fit

Patients with osteoarthritis of the glenohumeral joint, previous shoulder surgeries, or cognitive impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized controlled trial aims to evaluate the clinical outcomes and complications associated with self-locking biceps tenodesis versus double-loop 360 lasso biceps tenodesis for treating SLAP lesions in patients who do not have rotator cuff tears. The study seeks to address the lack of consensus on the optimal surgical approach for biceps pathology during shoulder arthroscopy. By comparing these two techniques, the trial hopes to provide clearer guidance on the best treatment options for affected patients.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced complications for patients undergoing biceps tendon repair.

How similar studies have gone: While previous studies have compared biceps tenotomy and tenodesis in patients with rotator cuff tears, this trial is novel as it focuses specifically on patients without such tears.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pathology of the LHBT or SLAP-type lesion based on clinical symptoms
* Partial-thickness rupture or absence of full-thickness rupture of the rotator cuff of the subscapular, supraspinatus and/or infraspinatus tendons, diagnosed preoperatively on ultrasound, arthro-CT or MRI

Exclusion Criteria:

* Full-thickness tears of the rotator cuff diagnosed preoperatively on ultrasound, arthro-CT or MRI.
* Osteoarthritis of the glenohumeral joint, defined by narrowing of the glenohumeral joint space or osteophytes, using AP radiography of the affected shoulder.
* Previous surgery on the affected shoulder
* Patients presenting with motor paralysis of the shoulder
* Preoperative presence of the Popeye sign or documented LHBT rupture
* Dementia or inability to complete questionnaires and assessments in French or English.
* Pregnant or breast-feeding patient
* Protected adult patient
* Patient not covered by social security.

Where it's running

  • Clinique Générale
    Annecy, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.